alexa Monoclonal antibodies, immunogenicity, and associated infusion reactions.
Dermatology

Dermatology

Journal of Clinical & Experimental Dermatology Research

Author(s): Cheifetz A, Mayer L

Abstract Share this page

Abstract The increasing use of monoclonal antibodies as treatment modalities for a number of immune mediated and malignant diseases has yielded great promise. In using this approach, however, we have encountered problems, in terms of infusion reactions. Two forms of reactions have been identified: acute and delayed; they appear to be related to the presence of antibodies to the monoclonal antibodies (against murine or human components). The reactions are largely not anaphylactic (IgE mediated), making it possible to re-treat patients using specific protocols. These protocols are detailed in this overview.
This article was published in Mt Sinai J Med and referenced in Journal of Clinical & Experimental Dermatology Research

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords